PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Insurance Benefits”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,351 records · Page 75Linked to original sources

Predicting the cost of mental health benefits.

Actuarial and economic methods are combined to predict the costs of mental health and substance abuse benefits in insurance. Costs are predicted for two employers under alternative benefit plans that contain some of the features proposed under national health reform. The cost of a given benefit differs greatly across population groups. In order to make accurate cost forecasts, data on the group's experience must be combined with research data on the impact of plan changes. Application of employers' experience and research from mental health economics can contribute to better public and private decisions, including those that are part of current health reform.

Cost Allocation↗

Employer drug benefit plans and spending on prescription drugs.

CONTEXT: With drug spending rising rapidly for working-aged adults, many employers and health insurance providers have changed benefits packages to encourage use of fewer or less expensive drugs. It is unknown how these initiatives affect drug costs. OBJECTIVE: To examine how innovations in benefits packages, such as those that include multitier formularies and mandatory generic substitution, affect total cost to insurance providers for generic and brand drugs and out-of-pocket payments to beneficiaries. DESIGN AND PARTICIPANTS: Retrospective study from 1997 to 1999 linking claims data of 420,786 primary beneficiaries aged 18 through 64 years who worked at large firms (n = 25) with health insurance benefits that included outpatient drugs. MAIN OUTCOME MEASURES: Overall drug costs; generic, single-source brand, and multisource brand costs; and drug expenditures by health insurance providers and out-of-pocket costs for beneficiaries. RESULTS: For a 1-tier plan with a 5 US dollars co-payment for all drugs, the average annual spending was 725 US dollars per member. Doubling co-payments to 10 US dollars for all drugs reduced the annual average drug cost from 725 US dollars to 563 US dollars per member (22.3%, P<.001). Doubling co-payments in a 2-tier plan from 5 US dollars for generics and $10 for brand drugs to 10 US dollars for generics and 20 US dollars for brand drugs reduced costs from 678 US dollars to 455 US dollars (32.9%, P<.001). Adding an additional co-payment of 30 US dollars for nonpreferred brand drugs to a 2-tier plan (10 US dollars generics; 20 US dollars brand) lowered overall drug spending by 4% (P<.001). Requiring mandatory generic substitution in a 2-tier plan reduced drug spending by 8% (P<.001). Doubling co-payments in a 2-tier plan increased the fraction beneficiaries' paid out-of-pocket from 17.6% to 25.6%. CONCLUSIONS: Adding an additional level of co-payment, increasing existing co-payments or coinsurance rates, and requiring mandatory generic substitution all reduced plan payments and overall drug spending among working-age enrollees with employer-provided drug coverage. The reduction in drug spending largely benefited health insurance plans because the percentage of drug expenses beneficiaries paid out-of-pocket rose significantly.

Adult↗

Determining the "Health Benefit Basket" of the Statutory Health Insurance scheme in Germany: methodologies and criteria.

The issue of defining health benefit catalogues has recently gained new importance in Germany as a result of the creation of the new Institute for Quality and Efficiency. The Institute was designed to support the Federal Joint Committee conducting effectiveness studies for benefit coverage decisions. The Committee and the contractual partners (sickness funds and providers) define the benefit catalogues for the Statutory Health Insurance in the framework of Social Code Book V, Germany's most relevant health care scheme. Unlike other countries, the German federal government limits its regulatory role to defining procedures that determine the scope of Statutory Health Insurance services. The explicitness of the benefit catalogues varies greatly between different sectors. While benefits in outpatient care are rather explicitly defined, benefit definitions for inpatient care are vague. It is argued that the establishment of the new Institute and the development of the DRG system are initial steps towards a more effective and explicit benefit catalogue.

Germany↗

Recommendations for the treatment of nicotine dependency.

The US Public Health Service (PHS) Clinical Practice Guideline Treating Tobacco Use and Dependence, published in June 2000, is a clinician-targeted resource that encourages physicians to apply evidence-based interventions when treating tobacco-dependent patients. Issued by the PHS Surgeon General, the guideline recommends a new standard of care in treating tobacco dependency, the chief cause of preventable death and disease in the United States. It calls on clinicians to more consistently identify and evaluate tobacco-dependent patients and to provide treatment, motivation to quit, and referrals to smoking cessation specialists. The guideline also serves as a mandate for healthcare insurers to offer pharmacologic and behavioral treatment modalities as benefits to insured persons and to provide education and reimbursement for clinicians.

Health Behavior↗

Benefits for individual retired workers and couples now approaching retirement age.

The first article in this issue of the Bulletin provides information on women and couples who were receiving retired-worker benefits in 1976. This article updates that information, focusing on potential full retired-worker benefits earned by men and women who will be reaching retirement age in the early 1980s. It is estimated that an increasing proportion of married women will become insured for benefits in their own right. Among female workers, the highest benefits are projected for those who never married. Divorced women show the next highest benefits, widowed woman are next, and then married women. Comparisons between men and women show little difference between the average benefits for those who never married; benefits for divorced women are projected to be about 80 percent of the benefits of divorced men; retired-worker benefits for married women are 58 percent as high as those for married men. This article also gives estimates of combined benefits for couples in which both husbands and wives will be insured workers. The highest average benefits are for couples in which the wife would be dually entitled; the lowest benefits are for couples in which the wife would receive only a spouse benefit.

Aged↗

The social roles of Medicare: assessing Medicare's collateral benefits.

The Medicare program incorporates a number of functions that go beyond providing health insurance to its beneficiaries. These activities, which we refer to as "collateral" functions, may have important health consequences but are also an increasing source of controversy. In this essay we develop a conceptual framework for categorizing these involvements, introduce some additional options that might complement Medicare's current collateral functions, assess the reaction of policy elites and Medicare's current beneficiaries to these alternatives, and evaluate the role that collateral activities play for Medicare's core mission. A case can be made for expanding some collateral involvements, but only if the Health Care Financing Administration has the strategic direction and administrative capacity to effectively implement these activities.

Aged↗